Crossmark

Entrectinib für die Therapie zugelassen

Crossref DOI link: https://doi.org/10.1007/s15004-020-8221-2

Published Online: 2020-09-14

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wedekind, Silke
License Information

Text and Data Mining valid from 2020-09-01

Version of Record valid from 2020-09-01
More Information

Article History

First Online: 14 September 2020

Free to read: This content has been made available to all.